F-box protein 22: A prognostic biomarker for colon cancer associated with immune infiltration and chemotherapy resistance

doi:10.4251/wjgo.v17.i4.102913

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (624)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

HTML

360

Figures (1-7)

Tables (1-1)

Sum=546

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=61

Apr 15, 2025 (publication date) through May 1, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Apr 15, 2025; 17(4): 102913
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.102913

Full Size Figure Download Figure

Figure 6 The prognostic significance of F-box protein 22 in colon adenocarcinoma patients. A and B: Kaplan-Meier curve analysis for the effect of F-box protein 22 expression on the prognosis of colon adenocarcinoma patients for overall survival; C: Kaplan-Meier curve analysis for the effect of F-box protein 22 expression on the prognosis of colon adenocarcinoma patients for progression-free survival. FBXO22: F-box protein 22; HR: Hazard ratio; PFI: Progression free interval.

Citation: Lu XF, Zhang HW, Chang X, Guo YZ. F-box protein 22: A prognostic biomarker for colon cancer associated with immune infiltration and chemotherapy resistance. World J Gastrointest Oncol 2025; 17(4): 102913
URL: https://www.wjgnet.com/1948-5204/full/v17/i4/102913.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i4.102913